Evidence map›Paper›PMID 37509429›Full record

ArticleBiomedicines2023

Characteristics of Intestinal Microbiota in Japanese Patients with Mild Cognitive Impairment and a Risk-Estimating Method for the Disorder.

Kouta Hatayama, Aya Ebara, Kana Okuma, Hidetaka Tokuno, Kazumi Hasuko, Hiroaki Masuyama, Iyoko Ashikari, Takuji Shirasawa

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution.

Kouta HatayamaSymbiosis Solutions Inc., Tokyo 101-0064, Japan.ORCID 0000-0002-1461-4797
Aya EbaraSymbiosis Solutions Inc., Tokyo 101-0064, Japan.
Kana OkumaSymbiosis Solutions Inc., Tokyo 101-0064, Japan.
Hidetaka TokunoSymbiosis Solutions Inc., Tokyo 101-0064, Japan.
Kazumi HasukoSymbiosis Solutions Inc., Tokyo 101-0064, Japan.
Hiroaki MasuyamaSymbiosis Solutions Inc., Tokyo 101-0064, Japan.ORCID 0000-0001-9425-0278
Iyoko AshikariAshikari Clinic, Tokyo 164-0011, Japan.
Takuji ShirasawaOchanomizu Health and Longevity Clinic, Tokyo 101-0062, Japan.ORCID 0000-0001-6370-0125
Solutions Inc. (Japan)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal microbiota may play a significant role in the development and progression of mild cognitive impairment (MCI). In addition, sex differences in the prevalence of MCI and intestinal microbiota are likely to exist. Therefore, this study investigated the association between MCI and intestinal microbiota by comparing Japanese patients in their 70s with MCI (11 males and 18 females) and disease-free controls (17 males and 23 females), taking sex into account. In both sexes,

Indexed as

intestinal microbiotaMCImild cognitive impairmentrisk estimationstructural equation modeling

Identifiers

PMID37509429
PMCPMC10376419
OpenAlexW4381741416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.